PATENT CLAIM ANALYSIS

Application Number: 16268367
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "469000"]

Abstract:
The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.

Claim (Index 10):
The method of  claim 7 , wherein R 1  and R 3  are deuterium and R 2  and R 4  are H.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 99.0
- Lexical Diversity: 1.12903
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16151641', '15545429', '12554737', '12553863', '12554719']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7251191241508451
- 35 USC 102 Novelty (BERT): 0.5013937362038585
- Combined Prediction Score: 0.7027465853561465
- Mean Citation Score: 190.063014
- Max Citation Score: 269.73154
- Similarity Product: 243.7269214990723

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test